Cost effectiveness of increasing the dose intensity of chemotherapy with granulocyte colony-stimulating factor in small-cell lung cancer: based on data from the Medical Research Council LU19 trial.
about
Cost-effectiveness of chemotherapy combined with thoracic radiotherapy versus chemotherapy alone for limited stage small cell lung cancer: A population-based propensity-score matched analysisPharmacoeconomics of the myeloid growth factors: a critical and systematic review.New G-CSF agonists for neutropenia therapy.
P2860
Cost effectiveness of increasing the dose intensity of chemotherapy with granulocyte colony-stimulating factor in small-cell lung cancer: based on data from the Medical Research Council LU19 trial.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Cost effectiveness of increasi ...... l Research Council LU19 trial.
@ast
Cost effectiveness of increasi ...... l Research Council LU19 trial.
@en
type
label
Cost effectiveness of increasi ...... l Research Council LU19 trial.
@ast
Cost effectiveness of increasi ...... l Research Council LU19 trial.
@en
prefLabel
Cost effectiveness of increasi ...... l Research Council LU19 trial.
@ast
Cost effectiveness of increasi ...... l Research Council LU19 trial.
@en
P2093
P1433
P1476
Cost effectiveness of increasi ...... l Research Council LU19 trial.
@en
P2093
David Girling
Laura Bojke
Mark Sculpher
Nick Thatcher
Richard Stephens
Wendi Qian
P304
P356
10.2165/00019053-200624050-00003
P577
2006-01-01T00:00:00Z
P6179
1003150269